{"news_desk": "Business", "print_page": "", "section_name": "Business Day", "subsection_name": "International Business", "document_type": "article", "multimedia": [], "abstract": null, "type_of_material": "News", "word_count": "272", "lead_paragraph": "Tests of drugs developed by GlaxoSmithKline and Merck are expected to begin in Liberia in two weeks, federal officials said.", "pub_date": "2015-01-23T00:00:00Z", "_id": "54c1d55d38f0d8389c2837db", "byline": {"contributor": "", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "source": "The New York Times", "snippet": "Tests of drugs developed by GlaxoSmithKline and Merck are expected to begin in Liberia in two weeks, federal officials said.", "web_url": "http://www.nytimes.com/2015/01/23/business/international/trial-of-2-ebola-vaccines-effectiveness-is-announced.html", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "is_major": "N", "value": "Ebola Virus", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "GlaxoSmithKline PLC", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Liberia", "name": "glocations"}, {"rank": "4", "is_major": "N", "value": "Merck & Company Inc", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Vaccination and Immunization", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Clinical Trials", "name": "subject"}], "headline": {"main": "Trial of 2 Ebola Vaccines\u2019 Effectiveness Is Announced"}}